Aarti Pharmalabs Profit & Loss Annual

Trade
BSE: 543748 | NSE: AARTIPHARM | ISIN: INE0LRU01027 | Sector: -
642.75 +36.40 (6.00%)Updated : 18 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,852.6191.8148.8824.12
Total Revenue 1,852.6191.8148.8824.12
Costof Revenue Total 1,020.7273.8812.296.41
Gross Profit 831.8917.9336.5917.71
Selling/ General/ Admin Expenses Total 138.413.552.381.24
Depreciation/ Amortization 73.242.101.511.45
Other Operating Expenses Total 307.441.9820.609.84
Total Operating Expense 1,539.8181.5136.7818.95
Operating Income 312.8010.3112.105.17
Interest Inc( Exp) Net- Non- Op Total -172.10-6.77-11.99-17.43
Other Net 4.900.000.000.00
Net Income Before Taxes 300.499.6310.903.42
Provisionfor Income Taxes 83.602.113.440.75
Net Income After Taxes 216.897.527.452.67
Net Income Before Extra Items 216.897.527.452.67
Net Income 216.897.527.452.67
Total Adjustmentsto Net Income 0.10-0.14-0.00
Income Availableto Com Excl Extra Ord 216.907.517.452.67
Income Availableto Com Incl Extra Ord 216.907.517.452.67
Diluted Net Income 216.907.517.452.67
Diluted Weighted Average Shares 9.060.951.221.22
Diluted EPS Excluding Extra Ord Items 23.937.946.092.18
DPS- Common Stock Primary Issue 3.000.50--
Diluted Normalized EPS 23.937.946.092.18
*All figures in crores except per share values
Recommended For You
Trending Stocks
491.85+14.50(3.04%)
3,589.00+61.40(1.74%)
12,576.20-275.00 (-2.14%)
181.15-1.90 (-1.04%)
HomeMarketsPremiumInstant LoanGet App